Applicant, as named in the Orange Book

Journey

Next listed expiry: Zilxi on 1 Oct 2030. 4 products with live protection, 2 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Zilxi minocycline hydrochloride	minocycline hydrochloride	213690	1 Oct 2030	patent
Qbrexza glycopyrronium tosylate	glycopyrronium tosylate	210361	28 Feb 2033	patent
Amzeeq minocycline hydrochloride	minocycline hydrochloride	212379	8 Sep 2037	patent, carve-out possible
Emrosi minocycline hydrochloride	minocycline hydrochloride	219015	7 Jan 2039	patent, carve-out possible

Products without listed protection (2)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Eurax crotamiton	crotamiton	006927	open now	no listed protection
Exelderm sulconazole nitrate	sulconazole nitrate	018737	open now	no listed protection